|
⚲
|
| Keyboard |
| Herron Jennifer Lyn
✚
|
|
|---|---|
| CIK # | 0001675774 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001675774] | |
| 4 | [0001675774] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ChemoCentryx Inc | |
| Herron Jennifer Lyn | |
| Genocea Biosciences Inc | |
| Ariad Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ChemoCentryx Inc CCXI
Common Stock
|
2022-10-20 | Disposed to issuer | 17,237 | ||
|
ChemoCentryx Inc CCXI
Common Stock
|
2022-06-28 | Grant | 17,237 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Stock Option (Right to Buy) · derivative
|
2021-09-09 | Grant | 30,000 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2017-02-16 | Disposed to issuer | 5,291 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Common Stock
|
2017-02-16 | Disposed to issuer | 450 | ||
|
Ariad Pharmaceuticals Inc ARIA
Employee Stock Option (Right to Buy) · derivative
|
2017-02-16 | Disposed to issuer | 300,000 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Restricted Stock Units · derivative
|
2017-02-06 | Grant | 5,291 | $0.00 | |
|
Ariad Pharmaceuticals Inc ARIA
Employee Stock Option (Right to Buy) · derivative
|
2016-05-31 | Grant | 300,000 | $8.85 | 2,655,000 |